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Background. Staphylococcus aureus bacteremia (SAB) is a serious cause of morbidity and mortality. This longitudinal study describes signiﬁcant reductions in hospital-onset SAB (HO-SAB) in Australian hospitals over the
past 12 years.
Methods. An observational cohort study design was used. Prospective surveillance of HO-SAB in 132 hospitals
in Australia was undertaken. Aggregated data from all patients who acquired HO-SAB was collected (deﬁned as 1 or
more blood cultures positive for S. aureus taken from a patient who had been admitted to hospital for >48 hours).
The primary outcome was the incidence of HO-SAB, including both methicillin-resistant (MRSA) and methicillinsusceptible (MSSA) S. aureus strains.
Results. A total of 2733 HO-SAB cases were identiﬁed over the study period, giving an aggregate incidence of
0.90 per 10 000 patient-days (PDs) (95% conﬁdence interval [CI], .86–.93). There was a 63% decrease in the annual
incidence, from 1.72 per 10 000 PDs in 2002 (95% CI, 1.50–1.97) to 0.64 per 10 000 PDs (95% CI, .53–.76) in 2013.
The mean reduction per year was 9.4% (95% CI, −8.1% to −10.7%). Signiﬁcant reductions in both HO-MRSA (from
0.77 to 0.18 per 10 000 PDs) and HO-MSSA (from 1.71 to 0.64 per 10 000 PDs) bacteremia were observed.
Conclusions. There was a major and signiﬁcant reduction in incidence of HO-SAB caused by both MRSA and
MSSA in Australian hospitals since 2002. This reduction coincided with a range of infection prevention and control
activities implemented during this time. It suggests that national and local efforts to reduce the burden of healthcareassociated infections have been very successful.
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In the past decade, efforts to decrease healthcareassociated infections (HAIs) have increased worldwide.
More than a decade ago, the landmark report “To Err Is
Human: Building a Safer Health System” had a major
impact on focusing the attention of policy makers, the
public, and healthcare workers (HCWs) on improving
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patient safety in healthcare facilities [1, 2]. In response,
HCWs, hospitals, and health authorities across the
world have increased efforts to keep people safe from
potential harm associated with receiving healthcare
[3, 4]. One infection of particular interest has been
Staphylococcus aureus bacteremia (SAB). Worldwide,
SAB is a serious cause of morbidity and mortality,
with associated mortality rates of 20%–50% [5–7] and
a signiﬁcant associated economic burden [8].
HAI surveillance programs have been established in
numerous countries to monitor and control the occurrence of HAIs. The prevention of infection requires a
multifaceted approach [9], often making it difﬁcult to
determine the relative effect of each intervention. In
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the case of SAB, interventions to reduce its incidence include
hand hygiene initiatives and improvements in the management
of intravascular catheters [10–13]. Despite global concerns
about serious HAIs such as SAB and the need to monitor the
effect of interventions, international comparisons are limited.
There are few longitudinal studies describing the incidence of
SAB across a wide region [14]. The purpose of this longitudinal
study is to describe signiﬁcant reductions in hospital-onset SAB
(HO-SAB) in Australian hospitals over the past 12 years.
METHODS
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Statistical analysis was conducted using IBM Statistics version
20.0. The incidence of HO-SAB per 10 000 PDs was calculated
as [HO-SAB cases / number of PDs × 10 000]; 95% conﬁdence
intervals (CIs) were calculated for Poisson distributed counts.
Monthly, quarterly, and yearly incidence rates were obtained
for HO-SAB. Monthly incidence of HO-SAB over the entire
study period was tested using time-series analysis (regression
analysis), to allow for autocorrelation between monthly measurements. Adjustment for seasonality was not undertaken.
To determine whether there was an issue of “dilution” of rates
from the later inclusion of PDs from smaller hospitals with a
much lower-risk patient population and very few episodes, further analysis was undertaken. First, when new hospitals contributed data, comparisons of the mean HO-SAB rate before and
after the addition of new hospitals were undertaken using
analysis of variance. Second, monthly aggregate incidence of
HO-SAB from the original 15 contributing hospitals and
from larger, more complex peer group hospitals ( principal referral hospitals as deﬁned by the Australian Institute of Health
and Welfare) [18] was analyzed separately over the entire study
period using time-series analysis.
Ethical Statement

This study was approved by the human research ethics committee at Avondale College of Higher Education (H0013060).
RESULTS
The number of hospitals contributing data to the state surveillance systems increased progressively from 15 in 2002 to 132
hospitals by 2011; this number was sustained until 2013. Of
these 132 hospitals, 81 were from SA, 46 from WA, 4 from
TAS, and 1 from ACT. A total of 2733 HO-SAB cases were identiﬁed over the study period, giving an aggregate incidence of
0.90 per 10 000 PDs (95% CI, .86–.93). There was a 63% decrease in the annual incidence, from 1.72 per 10 000 PDs in
2002 (95% CI, 1.50–1.97) to 0.64 per 10 000 PDs (95% CI,
.53–.76) in 2013. Further descriptive HO-SAB data by year
are presented in Table 1. Using time-series analysis (regression),
there was a mean reduction in the incidence of HO-SAB over
the entire study period of 9.4% per year (95% CI, −8.1% to
−10.7%; Figure 1).
Over the study period, the annual incidence of methicillinresistant S. aureus (MRSA) HO-SAB signiﬁcantly reduced by
76% from 0.77 to 0.18 per 10 000 PDs (P < .001). The proportion of HO-SAB that was caused by MRSA reduced from 44.7%
to 28.0%. Cases of HO-SAB caused by both MRSA and
methicillin-susceptible S. aureus (MSSA) signiﬁcantly reduced
during the study period (P < .001) (Table 1 and Figure 2). Aggregated data at the jurisdictional level also indicated a
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The study presents an analysis of prospective surveillance of
laboratory-diagnosed HO-SAB cases according to agreed deﬁnitions [15]. The primary outcome was HO-SAB, which was deﬁned as 1 or more blood cultures positive for S. aureus, taken
from a patient who had been admitted to hospital for >48
hours. The term HO-SAB is deﬁned as any case of SAB occurring >48 hours after admission. Only the ﬁrst isolate per patient
was counted, unless at least 14 days had passed without a positive blood culture, after which an additional episode was recorded. Surveillance data were collected and combined from
132 hospitals in 4 Australian states and territories, representing
24% of all Australian hospitals that reported having 1 or more
patient-days in 2011–2012. Of the 132 hospitals, 110 are publicly
funded; the reminder are privately funded. In Australia, approximately 68% of all hospital beds are publicly funded [16]. Data
from all admissions to inpatient wards or units within acute public hospitals, including psychiatric, rehabilitation, and aged care
admissions were included. For the period 1 January 2002–30
June 2013, HO-SAB surveillance and hospital bed-day data
were provided by the Australian Capital Territory (ACT), South
Australia (SA), Tasmania (TAS), and Western Australia (WA)
HAI surveillance units. All jurisdictions involved in this study
have a system where laboratory data can be directly extracted
and used for validation of reported cases. Data from the states
with larger populations (New South Wales, Victoria, and Queensland) were not available for the time period used for this study.
All contributing hospitals used the HO-SAB deﬁnition as described earlier and provided bed-day denominator data to the
HAI surveillance units. There were minor variations in the denominator used to calculate rates. ACT and WA used occupied
bed-days (OBDs) for the entire study period, whereas SA used
OBDs from 2002 to June 2006, and subsequently used patientdays [16]. Similarly, TAS used OBDs from 2005 until June 2008,
when patient days were subsequently used. The changes in denominators during the study period have negligible impact as
the yearly variance between the 2 measures (“occupied” compared to “patient” days) is estimated to be <1% [17]. For convenience, we use the term patient-days (PDs) for the remainder of
the paper.

Statistical Analysis

Table 1. Yearly Incidence of Hospital-Onset Staphylococcus aureus Bacteremia
Rate per 10 000 PDs
Hospitals

No. of PDs

MSSA (95% CI) (No.)

MRSA (95% CI) (No.)

SAB (95% CI) (No.)

2002
2003

15
15

1 208 009
1 231 463

0.95 (.79–1.14) (115)
0.74 (.59–.91) (91)

0.77 (.62–.94) (93)
0.60 (.47–.75) (74)

1.72 (1.50–1.97) (208)
1.34 (1.14–1.56) (165)

2004

15

1 230 235

0.78 (.63–.95) (96)

0.46 (.34–.59) (56)

1.24 (1.05–1.45) (152)

2005
2006

19
19

1 407 243
1 620 486

0.91 (.76–1.08) (128)
0.79 (.66–.94) (128)

0.47 (.36–.60) (66)
0.33 (.25–.43) (54)

1.38 (1.19–1.59) (194)
1.12 (.97–1.30) (182)

2007

22

2 081 367

0.65 (.55–.77) (136)

0.29 (.22–.38) (61)

0.95 (.82–1.09) (197)

2008
2009

65
68

3 566 709
3 686 420

0.71 (.63–.81) (254)
0.57 (.50–.65) (210)

0.24 (.19–.29) (85)
0.21 (.17–.26) (78)

0.95 (.85–1.06) (339)
0.78 (.69–.88) (288)

2010

74

3 922 593

0.62 (.54–.70) (242)

0.18 (.14–.23) (71)

0.80 (.71–.89) (313)

2011
2012

132
132

4 119 269
4 297 326

0.52 (.45–.60) (215)
0.44 (.38–.50) (187)

0.23 (.18–.28) (93)
0.16 (.12–.20) (68)

0.75 (.67–.84) (308)
0.59 (.52–.67) (255)

2013a

132

2 072 993

0.46 (.37–.56) (95)

0.18 (.13–.25) (37)

0.64 (.53–.76) (132)

Total

...

30 444 113

0.62 (.60–.65) (1897)

0.28 (.26–.29) (836)

0.90 (.86–.93) (2733)

Abbreviations: CI, confidence interval; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; PD, patient-days;
SAB, Staphylococcus aureus bacteremia.
a

Till 30 June 2013.

reduction in both MSSA and MRSA HO-SAB, consistent with
trends reported in Table 1 and Figure 1. These data are not speciﬁcally reported, as to do so would potentially identify individual hospitals.
During the study period, the number of hospitals contributing data increased from 15 to 132. When new hospitals contributed data, a signiﬁcant decrease in the mean incidence of
HO-SAB only occurred when the number of contributing hospitals increased from 16 to 19 in June 2005 (P = .02). There was
no further signiﬁcant change to the mean incidence of HO-SAB
when additional hospitals contributed data.

Figure 1. Quarterly incidence of hospital-onset Staphylococcus aureus
bacteremia—all hospitals, 2002 to 30 June 2013.

To test the possibility that dilution of rates was occurring by
the addition of lower-risk hospitals’ data, analysis of data from
the original 15 contributing hospitals was undertaken for the
entire study period. In these 15 hospitals, there was a signiﬁcant
reduction in the incidence of HO-SAB of 6.5% (95% CI, −4.9%
to −8.1%) per year, compared with 9.4% for the entire cohort of
hospitals. When analysis was performed on data from the principal referral hospitals only [18], there was an annual mean

Figure 2. Quarterly incidence of hospital-onset methicillin-resistant
Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia—all hospitals, 2002 to 30 June 2013.
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Year

reduction in the incidence of HO-SAB of 11.2% (95% CI, −9.2%
to −13.2%). Therefore, it is unlikely that there was a signiﬁcant
“dilution” effect caused by progressive inclusion of many smaller hospitals to account for the observed results.
DISCUSSION
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Our study reports a major, sustained, and signiﬁcant reduction
in HO-SAB in a large number of Australian hospitals since
2002. Although other studies have also documented a reduction
in national incidence of HO-SAB [11, 19–23] they have mostly
focused on MRSA. None have reported such a large reduction
in both MSSA and MRSA HO bacteremia. Additionally, we report longitudinal data, a key strength of our study.
Comparisons of the incidence of HO-SAB between countries
are difﬁcult, given the variety of deﬁnitions for cases and denominator data. In England, “Trust Apportioned” cases (occurring after the third day of admission) of MRSA bacteremia have
been collected since 2008. This has a close similarity to the HOSAB deﬁnition used in our study. Their data suggest that a signiﬁcant reduction in incidence of MRSA bacteremia occurred
between 2008–2009 and 2012–2013, from an incidence of
0.43–0.12 cases per 10 000 bed-days (P < .01) [21]. This latter
ﬁgure in England is lower than that reported in our study
for 2013 (0.18 per 10 000 PDs). It is not possible to determine
whether a reduction in MSSA bacteremia also occurred
in England during the same period, as these data are not
available.
In a Scottish study, the prevalence of HO-SAB in an inpatient
population reported a 41% decrease between 2006 and 2010,
from 0.73 to 0.50 cases per 1000 acute OBDs [19]. The incidence
of HO-MRSA bacteremia fell from 0.16 to 0.03 per 1000 acute
OBDs; however, unlike our study, the rates of HO-MSSA bacteremia remained unchanged. Their reported incidence of HOMRSA bacteremia is higher than the incidence in the last year of
our study (0.03 per 1000 acute OBDs vs 0.18 per 10 000 PDs),
assuming the calculation of bed-days is similar. The authors
suggested that the introduction of a universal MRSA admission
screening program was associated with signiﬁcant reductions in
rates of MRSA bacteremia but made no discernible impact on
burdens from MSSA bacteremia and that declines occurred almost exclusively in MRSA-related disease [19]. There is no national mandate regarding MRSA or MSSA patient screening in
Australia. Consistent with other studies, the Scottish study
found that upward pressure on MSSA rates was not observed,
and that MRSA appears to add to, rather than displace,
MSSA infection [20].
There are no national data from the United States on the incidence of HO-SAB; however, some studies provide insight into
trends. A study undertaken by Kallen and colleagues examined
invasive healthcare-associated MRSA infections in 9 metro-

politan areas [24]. In patients with an invasive HO-MRSA infection, the proportion of these caused by HO-MRSA bloodstream
infections decreased slightly from 87% to 84% between 2005
and 2008 (P = .06). A signiﬁcant reduction in MRSA bacteremia
related to a device was also identiﬁed in Veteran Affairs hospitals, after the introduction of MRSA prevention and control
bundle [23].
In the largest study of SAB to date, the incidence of SAB was
compared in 5 countries, incorporating nearly 20 000 episodes
[25]. During the 9 years studied, several regions reported decreases
in HO-MSSA, but only 2 regions observed a signiﬁcant decrease in
both HO-MSSA and HO-MRSA bacteremia (Copenhagen City
and Sherbrooke). In a recent study from Victoria in Australia,
data from 119 public and 4 private hospitals were analyzed
for a 3-year period (2010–2012) [26]. Healthcare-associated
SAB (ie, any case associated with receiving healthcare) infection
rates decreased from 1.4 to 0.7 per 10 000 OBDs (P < .001),
whereas healthcare-associated MRSA bacteremia decreased
from 0.4 to 0.1 per 10 000 OBDs (P < .001).
There are several potential explanations for the reduction in
HO-SAB described in our study. Australian states and territories have had a long history of implementing statewide infection
prevention and control initiatives. At a national level, the work
undertaken by the Australian Commission on Safety and Quality in Health Care (an independent statutory authority) in the
area of HAI prevention is notable [27]. The Commission has led
several major HAI prevention initiatives that were additional to
those from state and local hospital initiatives. These initiatives
included the development of national surveillance programs for
HAIs, national evidence-based guidelines, training and support
for improved clinician capacity in infection prevention and control, development of a national hand hygiene initiative, and new
accreditation standards. Hospitals who contributed data to this
study were involved in these national initiatives, in addition to
local and jurisdictional HAI prevention initiatives. The reduction in SAB observed in this study is unique, given the reduction
in both MSSA and MRSA HO-SAB. We believe a major factor
was that national, jurisdictional, and local interventions did not
just focus on MRSA, but on all cases of healthcare-associated
SAB and an overall effort to reduce all HAIs [10, 12, 26–28].
Regardless of how the data in our study are analyzed, a signiﬁcant downward trend in the incidence of HO-SAB, including MRSA and MSSA, is seen (Figure 3). To determine whether
the observed reduction in HO-SAB was simply offset by increased healthcare delivery in the community and a subsequent
increase in non-inpatient healthcare-associated SAB, we examined 2 further pieces of data. First, we explored hospital activity
data and found there was only a 0.7% reduction in the average
number of hospital beds per 1000 population in Australia between 2007–2008 and 2011–2012 [29]. We also identiﬁed a
2.7% increase in overnight admissions in Australian hospitals

over the same period [29]. Second, we examined non-inpatient
healthcare-associated SAB data for the 4 last years of our study
period in all jurisdictions. We found no evidence of an increase
in non-inpatient SAB during this time. Consequently, we are
conﬁdent that the decrease in HO-SAB observed in our study
was not offset by increases in non-inpatient SAB or changes
in the at risk population.
Our study is unique because we identiﬁed a signiﬁcant decrease in both MRSA and MSSA HO-SAB over the course of
the study and are unaware of any nation reporting similar ﬁndings in a longitudinal manner. Of the limited Australian population-based studies available, data suggest that the overall
incidence of SAB (including HO and community-onset cases)
has not signiﬁcantly increased or decreased in 2 regions within
Australia [25, 30]. Put simply, in Australia, reductions in
HO-SAB have not been driven by an overall reduction in the
incidence of SAB or reductions in either HO-MRSA or

HO-MSSA bacteremia individually, a point of distinction
from other notable studies [5, 11, 19].
A strength of this study is the application of a consistently
applied internationally recognized deﬁnition for HO-SAB,
and that data were captured for an extended period (12
years). However, a limitation of using this deﬁnition is that
not all cases of healthcare-associated SAB will be captured.
For example, cases of SAB occurring within 48 hours of hospitalization but associated with prior healthcare interventions
such as intravascular devices or surgery will not be included
[31]. Previous studies suggest that using a time frame of
48 hours postadmission will fail to identify approximately
30% of cases [26, 30]. It was not possible to obtain longitudinal
data using a more comprehensive healthcare-associated SAB
deﬁnition, as this approach did not commence in all states in
Australia until 2010. Further limitations of our study included
our inability to collect data on comorbidities, strain typing, and
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Figure 3. Yearly incidence of hospital-onset Staphylococcus aureus bacteremia (HO-SAB), 2002 to 30 June 2013. Abbreviations: MRSA, methicillinresistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; SAB, Staphylococcus aureus bacteremia.
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